“Big Data, Patents, and the Future of Medicine”

  • Law and Technology
  • Health Law
Cardozo Law Review
2016

“Making Elder Financial Exploitation Cases Part of a Sustainable Practice: Tips from the Experiences of the University of Illinois College of Law’s Elder Financial Justice Clinic”

  • Criminal Law
  • Health Law
Elder Law Journal
2016

“Regulating Secrecy”

  • Law and Technology
  • Health Law
Washington Law Review
2016

“Codon Influence on Large-Scale Protein Expression Correlates with E. coli mRNA Levels”

  • Law and Technology
  • Health Law
Nature
2016

“The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases”

  • Law and Technology
  • Health Law
Journal of Diabetes Science and Technology
2016

“Is the Chief Justice a Tax Lawyer?”

  • Administrative Law
  • Health Law
Pepperdine Law Review
2015

“The Disability Cliff”

  • Civil Rights
  • Health Law
Democracy
2015

“Black-Box Medicine”

  • Law and Technology
  • Health Law
Harvard Journal of Law & Technology
2015

“Innovation Policy Failures in the Manufacturing of Drugs”

  • Law and Technology
  • Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015

“Introduction to ‘Timing is Everything: Balancing Access and Uncertainty’ ”

  • Law and Technology
  • Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015

“Are Trade Secrets Delaying Biosimilars?”

  • Law and Technology
  • Health Law
Science
2015

“Will Clinical Trial Data Disclosure Reduce Incentives to Develop New Uses of Drugs?”

  • Law and Technology
  • Health Law
Nature Biotechnology
2015

“The Ordinary Remand Rule and the Judicial Toolbox for Agency Dialogue”

  • Constitutional Law
  • Health Law
George Washington Law Review
2014

“Generic Entry Jujitsu: Innovation and Quality in Drug Manufacturing”

  • Law and Technology
  • Health Law
IP Theory
2014

“Nudging the FDA”

  • Law and Technology
  • Health Law
The American Interest
2014

“Environmental Law, Public Health, and the Values Conundrum”

  • Criminal Law
  • Environmental and Energy Law
  • Public Interest Law
  • Health Law
Michigan Journal of Environmental and Administrative Law
2014

“Federalism by Waiver After the Health Care Case”

  • Health Law
The Health Care Case: The Supreme Court’s Decision and its Implications
2013

“Informed Consent for Return of Incidental Findings in Genomic Research”

  • Law and Technology
  • Health Law
Genetics in Medicine
2013

“Tattoos and IP Norms”

  • Intellectual Property and Antitrust
  • Health Law
Minnesota Law Review
2013

“Problems of Innovation-Deficient Pharmaceutical Manufacturing”

  • Law and Technology
  • Health Law
New England Journal of Medicine
2013

“A State-Time Epidemiology Model for Tuberculosis: Importance of Re-infection”

  • Health Law
Computational Biology and Chemistry
2012

“Unblocked Future: Why Gene Patents Won’t Hinder Whole-Genome Sequencing and Personalized Medicine”

  • Law and Technology
  • Health Law
Cardozo Law Review
2012

“The Past and Future of Deinstitutionalization Litigation”

  • Litigation
  • Health Law
Cardozo Law Review
2012

“Copyright Exhaustion and the Personal Use Dilemma”

  • Intellectual Property and Antitrust
  • Health Law
Minnesota Law Review
2012

“Large-Scale Experimental Studies Show Unexpected Amino Acid Effects on Protein Expression and Solubility in Vivo in E. coli”

  • Law and Technology
  • Health Law
Microbial Informatics and Experimentation
2011

“The Deepwater Horizon Oil Spill: Potential Insurance Coverage Implications”

  • Law and Technology
  • Health Law
Insurance Coverage Law Bulletin
2010

“Understanding the Physical Properties that Control Protein Crystallization by Analysis of Large-Sale Experimental Data”

  • Law and Technology
  • Health Law
Nature Biotechnology
2009

Law and the Contradictions of the Disability Rights Movement

  • Civil Rights
  • Health Law
2009

“Patenting Race: The Problems of Ethnic Genetic Testing Patents”

  • Law and Technology
  • Health Law
Columbia Science and Technology Law Review
2007

“Health and Human Rights”

  • Human Rights
  • Health Law
Public Health
2006

“The Perversity of Limited Civil Rights Remedies: The Case of ‘Abusive’ ADA Litigations”

  • Civil Rights
  • Health Law
UCLA Law Review
2006

“Disability, Life, Death, and Choice”

  • Civil Rights
  • Health Law
Harvard Journal of Law and Gender
2006

“Word Games: Raising and Resolving the Shortcomings in Accident-Insurance Doctrine that Autoerotic-Asphyxiation Cases Reveal”

  • Administrative Law
  • Health Law
Michigan Law Review
2005

“Pesticides, Children’s Health Policy, and Common Law Tort Claims”

  • Environmental and Energy Law
  • Health Law
Minnesota Journal of Law, Science and Technology
2005

“The Problem of New Uses”

  • Health Law
Yale Journal of Health Policy, Law, and Ethics
2005

“Judging the Schiavo Case”

  • Health Law
  • Civil Rights
Constitutional Commentary
2005

“Learning the Value of Drugs - Is Rofecoxib a Regulatory Success Story?”

  • Health Law
New England Journal of Medicine
2005

“Unterschiedliche Tarife für Männer und Frauen in der Privaten Krankenversicherung: ein Verstoß Gegen den Gleichheitssatz des Grundgesetzes?”

  • Human Rights
  • Health Law
Neue juristische Wochenschrift
2004

Review of The Company Doctor edited by John D. Donahue

  • Health Law
Journal of Policy Analysis and Management
2004

“The Future of Disability Law”

  • Civil Rights
  • Health Law
Yale Law Journal
2004

“Proprietary Considerations”

  • Health Law
Handbook of Stem Cells
2004

“The Supreme Court, the Americans with Disabilities Act, and Rational Discrimination”

  • Civil Rights
  • Health Law
Alabama Law Review
2004

“Reexamining Drug Regulation from the Perspective of Innovation Policy”

  • Health Law
Journal of Institutional and Theoretical Economics
2004

“MxA Gene Expression Analysis as an Interferon-beta Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity”

  • Law and Technology
  • Health Law
Molecular Diagnosis
2003

“Private Wealth and Public Health: A Critique of Richard Epstein’s Defense of the ‘Old’ Public Health”

  • Health Law
Perspectives in Biology and Medicine
2003

“Managed Care - The First Chapter Comes to a Close”

  • Health Law
University of Michigan Journal of Law Reform
1999

“Medical Rationing and the Allocation of Adjudicatory Responsibility under Comprehensive Health Care Reform in the 103rd Congress: An Administrative Lawyer’s Postmortem”

  • Health Law
Administrative Law Review
1995

“The Honest Scientist’s Guide to DNA Evidence”

  • Health Law
Human Identification: The Use of DNA Markers
1995

“The Honest Scientist’s Guide to DNA Evidence”

  • Health Law
Genetica
1995

“Tales of Two Cities: AIDS and the Legal Recognition of Domestic Partnerships in San Francisco and New York”

  • Civil Rights
  • Health Law
Law and Sexuality
1992